This moderated, live webinar will discuss the National Advisory Committee on Immunization (NACI) recommendations on seasonal influenza vaccine use for the 2023-2024 season. The webinar will address the role of health care providers in vaccine uptake and will include an overview of the antiviral treatment of influenza. Participants will also have the opportunity to ask questions.
At the end of this webinar, participants will be able to:
- Discuss with Canadians the importance of seasonal influenza vaccination.
- Identify and address barriers to seasonal influenza vaccine uptake.
- Apply the National Advisory Committee on Immunization (NACI) recommendations on seasonal influenza vaccine use for the 2023-2024 season.
- Identify where to access NACI guidance, Canadian influenza antiviral guidelines, and other resources relevant to the prevention and treatment of influenza during the 2023-2024 season.
This webinar will be delivered in English. At the end of the presentation, participants will be able to ask questions during a dedicated Q&A period in English.
Registrants are encouraged to submit questions of interest prior to the webinar to firstname.lastname@example.org.
Access instructions for the live event will be emailed to all registrants. Post event, a recording of the webinar will be posted on NCCID media channel.
The same webinar will be presented in French.
The webinar in French will take place on Wednesday, September 20, 2023, 12:00 pm – 1:00 pm EDT.
Register here for the webinar in French.
Claudyne Chevrier, PhD, National Collaborating Centre for Infectious Diseases
Dr. Robyn Harrison
Dr. Robyn Harrison is a Clinical Professor within the division of Infectious Diseases, Department of Medicine, at the University of Alberta. She works as an Infectious Disease Specialist in Edmonton, Alberta, and she is a Communicable Disease Consultant for the province-wide Alberta Health Services Workplace Health and Safety Program. Dr. Harrison is interested in policy development and support for clinicians to prevent infection transmission in healthcare settings. She is a member of the Alberta Advisory Committee on Immunization, and she participates in infection prevention working groups in the province of Alberta, including past work on pandemic influenza H1N1 in 2009, and avian influenza in 2014. At a national level, she is the Vice-Chair of Canada’s National Advisory Committee on Immunization and she has worked with the Public Health Agency of Canada as a member of the Prevention and Control of Occupational Infections in Health Care Settings Guideline Working Group.
Dr. Harrison obtained her medical degree at Dalhousie University, Nova Scotia; and she completed her Internal Medicine and Infectious Diseases subspecialty training at the University of Alberta. Most recently she completed an MSc in the combined areas of Public Health and Epidemiology through the London School of Hygiene and Tropical Medicine, England.
Dr. Jesse Papenburg
Dr. Jesse Papenburg is an Assistant Professor of Pediatrics and an Associate Member of the Department of Epidemiology, Biostatistics, and Occupational Health at McGill University. He practices Pediatric Infectious Diseases and Medical Microbiology at the Montreal Children’s Hospital of the McGill University Health Centre.
Dr. Papenburg obtained his medical degree from McGill University and completed residency and subspecialty training at the Montreal Children’s Hospital. He then completed a research fellowship on the molecular virology of RNA respiratory viruses at Laval University and an MSc in epidemiology at McGill. As a clinician scientist, Dr. Papenburg’s research is on the epidemiology of viral respiratory infections, with a focus on diagnostics to improve treatment and outcomes. He actively contributes to national and provincial guidelines on RSV immunoprophylaxis and influenza antiviral treatment.